interferon β-1b
Showing 1 - 25 of 8,471
Learn About Interferon-beta Exposure of Pregnant Women During
Not yet recruiting
- Multiple Sclerosis (MS)
- Avonex (IFNβ-1-a, Biogen Netherlands B.V)
- +5 more
-
Multiple Locations, Finland
- +1 more
Sep 19, 2023
Corona Virus Infection, Sars-CoV2 Trial in France (Vitamins, Telmisartan, Ciclesonide)
Completed
- Corona Virus Infection
- Sars-CoV2
- Vitamins
- +3 more
-
Bordeaux, France
- +6 more
Feb 3, 2022
Covid19 Trial in Hong Kong (Interferon beta-1b, Remdesivir)
Recruiting
- Covid19
- Interferon beta-1b
- Remdesivir
-
Hong Kong, Hong KongQueen Mary Hospital
Dec 9, 2020
COVID Trial in Hong Kong (Interferon Beta-1B, Hydroxychloroquine)
Completed
- COVID
- Interferon Beta-1B
- Hydroxychloroquine
-
Hong Kong, Hong KongThe University of Hong Kong, Queen Mary Hospital
Jul 27, 2020
Metastatic Myxoid Liposarcoma, Metastatic Round Cell Liposarcoma, Metastatic Synovial Sarcoma Trial in United States (Interferon
Active, not recruiting
- Metastatic Myxoid Liposarcoma
- +15 more
- Interferon Gamma-1b
- +2 more
-
Palo Alto, California
- +6 more
Aug 2, 2022
HLA-A2 Positive Cells Present, Refractory Melanoma Trial in Buffalo (Alpha-type-1 Polarized Dendritic Cells, Celecoxib, PD-1
Recruiting
- HLA-A2 Positive Cells Present
- Refractory Melanoma
- Alpha-type-1 Polarized Dendritic Cells
- +5 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Dec 12, 2022
Melanoma Trial in Xi'an (Recombinant human interferon a1b, Toripalimab, Anlotinib HCl)
Not yet recruiting
- Melanoma
- Recombinant human interferon α1b
- +2 more
-
Xi'an, Shaanxi, ChinaAir Force Military Medical University/ Fourth Military Medical U
Sep 13, 2022
Multiple Sclerosis Trial in Shreveport (Interferon beta 1a, oral doxycycline)
Completed
- Multiple Sclerosis
- Interferon beta 1a, oral doxycycline
-
Shreveport, LouisianaLSU Health Sciences Center Shreveport
Oct 11, 2022
Recurrent B Acute Lymphoblastic Leukemia, Recurrent B-Cell Non-Hodgkin Lymphoma, Refractory B Acute Lymphoblastic Leukemia Trial
Not yet recruiting
- Recurrent B Acute Lymphoblastic Leukemia
- +5 more
- Interferon Beta-1A
- +10 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 6, 2023
Chronic Pulmonary Aspergillosis, Aspergillosis Trial (Interferon Gamma-1B 0.1 MG Per 0.5 ML Injection PLUS antifungals as
Not yet recruiting
- Chronic Pulmonary Aspergillosis
- Aspergillosis
- Interferon Gamma-1B 0.1 MG Per 0.5 ML Injection PLUS antifungals as standard of care
- Antifungals as standard of care
- (no location specified)
Dec 13, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma, Unresectable Triple-Negative Breast
Not yet recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +2 more
- Biopsy
- +7 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Feb 23, 2023
Multiple Sclerosis Trial in Worldwide (Interferon beta-1a, Fingolimod, Placebo capsule)
Recruiting
- Multiple Sclerosis
- Interferon beta-1a
- +3 more
-
Birmingham, Alabama
- +106 more
Jan 13, 2023
Candidemia Trial in Worldwide (Interferon Gamma-1B)
Recruiting
- Candidemia
- Interferon Gamma-1B
-
Durham, North Carolina
- +4 more
Mar 14, 2022
Anogenital Wart Trial in Makassar (Topical Ethanol Extract (Piper crocatum), Trichloroacetic Acid Topical)
Not yet recruiting
- Anogenital Wart
- Topical Ethanol Extract (Piper crocatum)
- Trichloroacetic Acid Topical
-
Makassar, South Sulawesi, IndonesiaWahidin Sudirohusodo General Hospital
Nov 14, 2022
COVID-19, INTERFERON, NEBULIZATION Trial in France (inhaled type I interferon, WFI water nebulization)
Recruiting
- COVID-19
- +2 more
- inhaled type I interferon
- WFI water nebulization
-
Abbeville, France
- +6 more
Jan 3, 2022
Anti-PD-1/PD-L1 Antibodies Plus Pegylated Interferon Alfa-2b
Recruiting
- Hepatocellular Carcinoma
- Anti-PD-1/PD-L1
- PEG-Interferon Alfa
-
Shanghai, ChinaZhongshan Hospital, Fudan University
Mar 28, 2022
COVID-19 Virus Infection Trial in Milano (Interferon-ß-1a, Standard of Care (SOC))
Terminated
- COVID-19 Virus Infection
- Interferon-ß-1a
- Standard of Care (SOC)
-
Milano, ItalyIRCCS Ospedale San Raffaele
Apr 28, 2021
Metastatic Carcinoma in the Liver, Recurrent Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v7 Trial in Buffalo (drug,
Completed
- Metastatic Carcinoma in the Liver
- +4 more
- Celecoxib
- +3 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Feb 25, 2022
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- +2 more
- Best Practice
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Mar 1, 2022
Relapsing Remitting Multiple Sclerosis Trial (Laquinimod, Avonex®)
Withdrawn
- Relapsing Remitting Multiple Sclerosis
- (no location specified)
Nov 5, 2021
HIV Trial in Philadelphia, Houston (Interferon gamma-1b)
Completed
- HIV Infections
- Interferon gamma-1b
-
Philadelphia, Pennsylvania
- +1 more
Oct 27, 2021
Critically Ill Patients Trial in France, Greece, Spain (Recombinant Interferon gamma 1b (IMUKIN®), Recombinant Interferon gamma
Active, not recruiting
- Critically Ill Patients
- Recombinant Interferon gamma 1b (IMUKIN®)
- Recombinant Interferon gamma 1b placebo
-
Angers, France
- +17 more
Feb 1, 2022
Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting Trial in Germany, United States (Tetanus, diphtheria, and acellular
Recruiting
- Multiple Sclerosis
- Multiple Sclerosis, Relapsing-Remitting
- Tetanus, diphtheria, and acellular pertussis vaccine
- +2 more
-
Palo Alto, California
- +47 more
Jun 24, 2022
Merkel Cell Polyomavirus Infection, Stage IV Merkel Cell Carcinoma AJCC v7 Trial in Seattle (drug, other, biological, radiation)
Terminated
- Merkel Cell Polyomavirus Infection
- Stage IV Merkel Cell Carcinoma AJCC v7
- Avelumab
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Feb 25, 2022